Board Meeting3 Aug 2026, 12:33 pm
iSERA Lifesciences Board Meeting on Aug 7 to Approve Unaudited Results
AI Summary
iSERA Lifesciences Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda item for this meeting is to consider and approve the company's Unaudited Financial Results for the quarter ending June 30, 2026. Additionally, the company has informed that the trading window for its equity shares will be closed for designated persons from July 1, 2026, until 48 hours after the results are publicly disclosed. The notice regarding this meeting and trading window closure is available on the company's website and the BSE India website.
Key Highlights
- Board meeting scheduled for August 7, 2026.
- To consider and approve Unaudited Financial Results.
- Results are for the quarter ended June 30, 2026.
- Trading window closed from July 1, 2026.
- Information available on company and BSE websites.
Price Impact
More from COVIDH